| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.0008 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |